Effect of interferon-γ on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts

BMB Reports

Volumn 45, Issue 5, 2012, Pages 281-286

  Kim, Jeung Woo ^a   Lee, Myeung Su ^a   Lee, Chang Hoon ^a   Kim, Ha Young ^b   Chae, Soo Uk ^c   Kwak, Han Bok ^d,e   Oh, Jaemin ^d,e  

^a Wonkwang University School of Medicine   (South Korea)

^b Sanbon Medical Center   (South Korea)

^c Gunsan Medical Center   (South Korea)

^d Wonkwang University   (South Korea)

^e Wonkwang Institute for Skeletal Disease   (South Korea)

Author keywords

Fusion; Interferon; Osteoclasts

Indexed keywords

BONE RESORPTION FACTOR; CYTOKINE; GAMMA INTERFERON;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUSION; CELL NUCLEUS; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION; GENETICS; GIANT CELL; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL FUSION; CELL NUCLEUS; CELLS, CULTURED; CYTOKINES; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; GIANT CELLS; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED ICR; OSTEOCLASTS; UP-REGULATION;

EID: 84863466353     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.5.281     Document Type: Article

References (29)

1. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289, 1504-1508.
2. Boyle, W. J., Simonet, W. S. and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342.
3. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T. and Martin, T. J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357.
4. Tsukii, K., Shima, N., Mochizuki, S., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T. and Higashio, K. (1998) Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 246, 337-341.
5. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E. and Capparelli, C. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis. Nature 397, 315-323.
6. Fuller, K., Wong, B., Fox, S., Choi, Y. and Chambers, T. J. (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188, 997-1001.
7. Rodan, G. A. and Martin, T. J. (2000) Therapeutic approaches to bone diseases. Science 289, 1508-1514.
8. Josien, R., Wong, B. R., Li, H. L., Steinman, R. M. and Choi, Y. (1999) TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 162, 2562-2568.
9. Matsuo, K., Owens, J. M., Tonko, M., Elliott, C., Chambers, T. J. and Wagner, E. F. (2000) Fosl1 is a transcription target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184-187.
10. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T. and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901.
11. Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Ohnishi, H., Matozaki, T., Kodama, T., Taniguchi, T., Takayanagi, H. and Takai, T. (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763.
12. Mócsai, A., Humphrey, M. B., Van Ziffle, J. A., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A. and Nakamura, M. C. (2004) The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci .U.S.A. 101, 6158-6163.
13. Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E. and Takayanagi, H. (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269.
14. Takayanagi, H. (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83, 170-179.
15. Kim, K., Lee, S. H., Kim, J. H., Choi, Y. and Kim, N. (2008) NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22, 176-185.
16. de Vries, T. J., Schoenmaker, T., Beertsen, W., van der Neut, R. and Everts, V. (2005) Effect of CD44 deficiency on in vitro and in vivo osteoclast formation. J. Cell. Biochem. 94, 954-966.
17. Mbalaviele, G., Chen, H., Boyce, B. F., Mundy, G. R. and Yoneda, T. (1995) The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J. Clin. Invest. 95, 2757-2765.
18. Abe, E., Mocharla, H., Yamate, T., Taguchi, Y. and Manolagas, S. C. (1999) Meltrin-α, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif. Tissue Int. 64, 508-515.
19. Lee, S. H., Rho, J., Jeong, D., Sul, J. Y., Kim, T., Kim, N., Kang, J. S., Miyamoto, T., Suda, T., Lee, S. K., Pignolo, R. J., Koczon-Jaremko, B., Lorenzo, J. and Choi, Y. (2006) v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12, 1403-1409.
20. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y. and Suda, T. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202, 345-351.
21. Lee, M. S., Kim, H. S., Yeon, J. T., Choi, S. W., Chun, C. H., Kwak, H. B. and Oh, J. (2009) GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway. J. Immunol. 183, 3390-3399.
22. Takayanagi, H., Kim, S., Matsuo, K., Suzuki, H., Suzuki, T., Sato, K., Yokochi, T., Oda, H., Nakamura, K., Ida, N., Wagner, E. F. and Taniguchi, T. (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416, 744-749.
23. Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K. and Taniguchi, T. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408, 600-605.
24. Gao, Y., Grassi, F., Ryan, M. R., Terauchi, M., Page, K., Yang, X., Weitzmann, M. N. and Pacifici, R. (2007) IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117, 122-132.
25. Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., Cua, D. J. and Takayanagi, H. (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673-2682.
26. Hartgers, F. C., Vissers, J. L., Looman, M. W., van Zoelen, C., Huffine, C., Figdor, C. G. and Adema, G. J. (2000) DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur. J. Immunol. 30, 3585-3590.
27. Shaw, J. P., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A. and Crabtree, G. R. (1998) Identification of a putative regulator of early T cell activation genes. Science 241, 202-205.
28. Skurkovich, S. V. and Eremkina, E. I. (1975) The probable role of interferon in allergy. Ann. Allergy 35, 356-360.
29. Hu, X. and Ivashkiv, L. B. (2009) Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31, 539-550.